The state of North Carolina currently has 14 active clinical trials seeking participants for Epilepsy research studies. These trials are conducted in various cities, including Durham, Winston-Salem, Charlotte and Chapel Hill.
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
NCT05104983
Recruiting
This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC infants. This study is supported by research funding from the Office of Orphan Products Division (OOPD) of the US Food and Drug Administration (FDA).
Gender:
All
Ages:
Between 1 day and 6 months
Trial Updated:
08/21/2023
Locations: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Conditions: Tuberous Sclerosis Complex, Epilepsy
Register for Updates
Neonatal Seizure Registry - Developmental Functional EValuation
NCT04337697
Recruiting
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.
Gender:
All
Ages:
Between 2 years and 8 years
Trial Updated:
08/08/2023
Locations: Duke University, Durham, North Carolina
Conditions: Neonatal Seizure, Hypoxic-Ischemic Encephalopathy, Stroke, Intracranial Hemorrhages, Epilepsy, Cerebral Palsy, Intellectual Disability
Register for Updates